Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-05-19 16:08:09 ET · period of report 2026-05-15 · accession 0001628280-26-036427 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 16:08 | 2026-05-15 | TLSI | Marshak Richard | Chief Commercial Off | S - Sale | $2.67 | -543 | 125.1K | -0.4% | -$1,450 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | S | D | 543 | $2.67 | 125,101 | D | — | — | (F1) Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. |